John David Mccann, MD PHD | |
1410 Forum Katy Pkwy Ste 100, Columbia, MO 65203-6583 | |
(573) 441-7070 | |
(573) 441-2288 |
Full Name | John David Mccann |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1410 Forum Katy Pkwy Ste 100, Columbia, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326006917 | NPI | - | NPPES |
100506327 | Medicaid | NV | |
PAR TAX ID | Other | GEHA | |
1057048 | Other | CCN | |
521709 | Other | DMBA | |
805502900 | Medicaid | ID | |
107030566101 | Other | UT | IHC SELECT HEALTH |
107030566101 | Other | IHC | |
5069010 | Other | AETNA | |
PAR TAX ID | Other | BEECH STREET | |
114400600 | Medicaid | WY | |
8806278 | Other | CIGNA | |
PAR TAX ID | Other | MAILHANDLERS | |
015005 | Other | ALTIUS | |
1057048 | Other | FIRST HEALTH | |
PAR TAX ID | Other | BLUE CROSS OF CA |
Mailing Address | Practice Location Address |
---|---|
John David Mccann, MD PHD 1410 Forum Katy Pkwy Ste 100, Columbia, MO 65203-6583 Ph: (573) 441-7070 | John David Mccann, MD PHD 1410 Forum Katy Pkwy Ste 100, Columbia, MO 65203-6583 Ph: (573) 441-7070 |
News Archive
Mylan Inc. today announced that the company will be added to the NASDAQ-100 Index Dec. 21. Mylan's common shares will also be included in NASDAQ's PowerShares QQQ.
Studies Suggest that ErbB4 Receptor Activation May Be a Novel Therapeutic Avenue for Intestinal Diseases Involving Epithelial Cell Death, According to Research Published in The American Journal of Pathology
A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease. This real-life' view of the HCV patient care continuum in a major U.S. urban area is published in Hepatology, a journal of the American Association for the Study of Liver Diseases, and highlights the importance of generating awareness among clinicians and at-risk groups about appropriate HCV testing, referral, support and care.
A drug-eluting coronary stent made of absorbable material performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction (STEMI), according to results of the ABSORB STEMI TROFI II trial.
› Verified 1 days ago
Mohannad Al-samarraie, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3215 Wingate Ct, Suite 102, Columbia, MO 65201 Phone: 573-882-8920 Fax: 573-884-4868 | |
Vaishnavi Balendiran, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-884-3937 Fax: 573-884-5575 | |
Dr. Jella Angela An, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Drive, Columbia, MO 65212 Phone: 573-882-1506 Fax: 573-884-5575 | |
Maggie A Cardonell, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3215 Wingate Court, Ste 102, Columbia, MO 65201 Phone: 573-882-8920 Fax: 573-884-4868 | |
Dr. Tricia Ann Fernandez, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3215 Wingate Ct, Columbia, MO 65201 Phone: 573-884-3937 Fax: 573-884-4868 | |
Maxwell Court, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: University Hospital One Hospital Dr Dc.052.00, Columbia, MO 65212 Phone: 573-882-4688 Fax: 573-884-1858 | |
Dr. Kathy J Lentz, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Mason Eye Institute University Of Missouri, 1 Hospital Drive, Columbia, MO 65212 Phone: 573-882-1027 |